217 related articles for article (PubMed ID: 17523003)
1. Porous carrier based floating granular delivery system of repaglinide.
Jain SK; Agrawal GP; Jain NK
Drug Dev Ind Pharm; 2007 Apr; 33(4):381-91. PubMed ID: 17523003
[TBL] [Abstract][Full Text] [Related]
2. A novel calcium silicate based microspheres of repaglinide: in vivo investigations.
Jain SK; Agrawal GP; Jain NK
J Control Release; 2006 Jun; 113(2):111-6. PubMed ID: 16759733
[TBL] [Abstract][Full Text] [Related]
3. Controlled release calcium silicate based floating granular delivery system of ranitidine hydrochloride.
Jain AK; Jain SK; Yadav A; Agrawal GP
Curr Drug Deliv; 2006 Oct; 3(4):367-72. PubMed ID: 17076638
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of porous carrier-based floating granular delivery system of orlistat.
Jain SK; Agrawal GP; Jain NK
PDA J Pharm Sci Technol; 2008; 62(4):292-9. PubMed ID: 19174957
[TBL] [Abstract][Full Text] [Related]
5. Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization.
Jain SK; Awasthi AM; Jain NK; Agrawal GP
J Control Release; 2005 Oct; 107(2):300-9. PubMed ID: 16095748
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of porous carrier-based floating orlistat microspheres for gastric delivery.
Jain SK; Agrawal GP; Jain NK
AAPS PharmSciTech; 2006 Nov; 7(4):90. PubMed ID: 17233542
[TBL] [Abstract][Full Text] [Related]
7. Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet.
Qin C; He W; Zhu C; Wu M; Jin Z; Zhang Q; Wang G; Yin L
Int J Pharm; 2014 May; 466(1-2):276-85. PubMed ID: 24607209
[TBL] [Abstract][Full Text] [Related]
8. In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats.
Rawat MK; Jain A; Singh S
J Pharm Sci; 2011 Jun; 100(6):2406-17. PubMed ID: 21491451
[TBL] [Abstract][Full Text] [Related]
9. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
10. Development and in vivo floating behavior of verapamil HCl intragastric floating tablets.
Patel A; Modasiya M; Shah D; Patel V
AAPS PharmSciTech; 2009; 10(1):310-5. PubMed ID: 19296224
[TBL] [Abstract][Full Text] [Related]
11. Gamma scintigraphic study of the hydrodynamically balanced matrix tablets of Metformin HCl in rabbits.
Razavi M; Karimian H; Yeong CH; Sarji SA; Chung LY; Nyamathulla S; Noordin MI
Drug Des Devel Ther; 2015; 9():3125-39. PubMed ID: 26124637
[TBL] [Abstract][Full Text] [Related]
12. Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation.
Rawat MK; Jain A; Singh S
J Pharm Sci; 2011 Jun; 100(6):2366-78. PubMed ID: 21491449
[TBL] [Abstract][Full Text] [Related]
13. Effect of HPMC and Carbopol on the release and floating properties of Gastric Floating Drug Delivery System using factorial design.
Li S; Lin S; Daggy BP; Mirchandani HL; Chien YW
Int J Pharm; 2003 Mar; 253(1-2):13-22. PubMed ID: 12593933
[TBL] [Abstract][Full Text] [Related]
14. Preparation and pharmacokinetics study on gastro-floating sustained-release tablets of troxipide.
Gao Y; Gao Y; Yin F; Wang M; Wang Z; Ye T; Yang Y; Pan WS; Yang X
Drug Dev Ind Pharm; 2015; 41(9):1443-51. PubMed ID: 25190152
[TBL] [Abstract][Full Text] [Related]
15. Design and in vitro and in vivo characterization of mucoadhesive matrix pellets of metformin hydrochloride for oral controlled release: a technical note.
Ige PP; Gattani SG
Arch Pharm Res; 2012 Mar; 35(3):487-98. PubMed ID: 22477196
[TBL] [Abstract][Full Text] [Related]
16. Formulation and in vitro, in vivo evaluation of effervescent floating sustained-release imatinib mesylate tablet.
Kadivar A; Kamalidehghan B; Javar HA; Davoudi ET; Zaharuddin ND; Sabeti B; Chung LY; Noordin MI
PLoS One; 2015; 10(6):e0126874. PubMed ID: 26035710
[TBL] [Abstract][Full Text] [Related]
17. Formulation and development of gastroretentive drug delivery system for ofloxacin.
Ali J; Hasan S; Ali M
Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):433-9. PubMed ID: 17003848
[TBL] [Abstract][Full Text] [Related]
18. Fast dissolving electrospun polymeric films of anti-diabetic drug repaglinide: formulation and evaluation.
Thakkar S; More N; Sharma D; Kapusetti G; Kalia K; Misra M
Drug Dev Ind Pharm; 2019 Dec; 45(12):1921-1930. PubMed ID: 31625774
[No Abstract] [Full Text] [Related]
19. Development and evaluation of gastroretentive norfloxacin floating tablets.
Bomma R; Swamy Naidu RA; Yamsani MR; Veerabrahma K
Acta Pharm; 2009 Jun; 59(2):211-21. PubMed ID: 19564145
[TBL] [Abstract][Full Text] [Related]
20. Improved oral bioavailability of repaglinide, a typical BCS Class II drug, with a chitosan-coated nanoemulsion.
Karami Z; Saghatchi Zanjani MR; Nasihatsheno N; Hamidi M
J Biomed Mater Res B Appl Biomater; 2020 Apr; 108(3):717-728. PubMed ID: 31187938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
